Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

MEK1 (human), (recombinant) (His-tag)

 
BML-SE509-0020 20 µg 392.00 USD
Do you need bulk/larger quantities?
 

Product Specification

Alternative Name:MAPK2K1, MAPKK1, MAP kinase kinase 1, MAPK/ERK kinase 1
 
MW:~43kDa
 
Source:Produced in E. coli. Active full length MEK1 (MAPK2K1) with C- and N-terminal His-tags. Genbank ID No. NM_002755.
 
UniProt ID:Q02750
 
Formulation:Liquid. In 50mM TRIS-HCl, pH 8.0, containing 150mM sodium chloride, 5mM DTT, 0.03% Brij-35, 20% glycerol.
 
Purity:≥85% (SDS-PAGE)
 
Purity Detail:Purified by multi-step chromatography.
 
Specific Activity:≥12 pmol/min/µg. Kinase activity was measured using the non-radioactive ADP Hunter Plus kit™.
 
Application Notes:Useful tool to study enzyme regulation and kinetics, phosphorylate target substrates, screen for inhibitors.
 
Shipping:Shipped on Dry Ice
 
Long Term Storage:-80°C
 
Use/Stability:After initial defrost, aliquot product into individual tubes and refreeze at -80°C. Avoid repeated freeze/defrost cycles.
 
Scientific Background:MEK1 is a dual-specificity kinase that phosphorylates ERK1/2, activating it in response to extracellular and intracellular signals. It also acts to downregulate PPAR γ by a direct interaction that results in PPAR γ moving into the cytoplasm from the nucleus.
 

General Literature References

Differential regulation and properties of MAPKs.: M. Raman et al.; Oncogene 26, 3100 (2007),
Interaction with MEK causes nuclear export and downregulation of peroxisome proliferator-activated receptor gamma.: E. Burgermeister et al.; Mol. Cell Biol. 27, 803 (2007),

Product Toolbox

PRODUCT RESOURCES

Datasheet
MSDS
Certificate of Analysis

RELATED PRODUCTS

By target:
MEK
By biological activity:
MEK Recombinant protein
By catalog section:

PRODUCT SUPPORT

FAQs
Technical Service
Customer Service

Recommend this page

 
For Research Use Only. Not for use in diagnostic procedures.
Keep in touch

©2017 Enzo Life Sciences, Inc.,